Skip to main content

Zevia PBC (ZVIA) Stock Forecast

Data as of Jun 16, 2026

Consumer Defensive · Current price $1.29 (+1.97%)

Consensus Target
$3.50
Upside
+132.9%
Analysts
2
Rating
Buy(2.00)

Price Target Range

Low $3.00Consensus $3.50High $4.00
▲ Current $1.29

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Aug 14, 2025Sarang VoraTelsey Advisory$6.00+363.3%
May 9, 2024Alton StumpLoop Capital Markets$2.00+54.4%
May 9, 2024Dana TelseyTelsey Advisory$2.00+54.4%
Jul 25, 2023Dana TelseyTelsey Advisory$4.00+208.9%

ZVIA vs Sector & Market

MetricZVIAConsumer Defensive AvgLarge Cap Avg
Analyst Rating2.002.562.40
Analyst Count21119
Target Upside+132.9%+922.9%+17.1%
P/E Ratio-8.2811.5031.64

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$171M$171M$171M5
2027-12-31$180M$182M$183M4
2028-12-31$197M$197M$197M2

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-0.12$-0.09$-0.063
2027-12-31$-0.05$-0.04$-0.042
2028-12-31$0.00$0.00$0.002

Frequently Asked Questions

What is the analyst consensus for ZVIA?

The consensus among 2 analysts covering Zevia PBC (ZVIA) is Buy with an average price target of $3.50.

What is the highest price target for ZVIA?

The highest price target for ZVIA is $6.00, set by Sarang Vora at Telsey Advisory on 2025-08-14.

What is the lowest price target for ZVIA?

The lowest price target for ZVIA is $2.00, set by Dana Telsey at Telsey Advisory on 2024-05-09.

How many analysts cover ZVIA?

2 analysts have issued ratings for Zevia PBC in the past 12 months.

Is ZVIA a buy or sell right now?

Based on 2 analyst ratings, ZVIA has a consensus rating of Buy (2.00/5) with a +132.9% upside to the consensus target of $3.50.

What are the earnings estimates for ZVIA?

Analysts estimate ZVIA will report EPS of $-0.09 for the period ending 2026-12-31, with revenue estimated at $171M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.